Now you can get access to the latest and highest-quality analysis of recent Wall Street buying and selling ideas with just one subscription to Beyond the Wall Investing ! There is a free trial and a special discount of 10% for you. Join us today! I initiated coverage of Bristol Myers Squibb Company (NYSE: BMY ) stock in late March 2024 with a "Buy" rating. At the time, I cited that the company's growth potential wasn't exactly what made it worth buying, but Daniel Sereda is chief investment analyst at a fam ...